BISTTRY12:18Live
RTALB Ratio Analysis: P/E, P/B, EV/EBITDARta Laboratuvarları Biyolojik Ürünler İlaç ve Makine Sanayi Ticaret A.Ş.
Main MarketChemicals, Petroleum, Rubber and Plastics
2.010.04 (2.03%)
- Volume
- TRY 9.5M
- Day range
- 1.97 – 2.01
- Previous close
- 1.97
- Market cap
- TRY 1B
Last updated: Source: Borsa Istanbul, 15-minute delayed
35 key ratios for Rta Laboratuvarları Biyolojik Ürünler İlaç ve Makine Sanayi Ticaret A.Ş. (RTALB) computed from the latest financial statements and the current price: valuation, profitability, liquidity, leverage and efficiency.
Ratio Analysis
| P/E | — |
| P/B | 0.35 |
| EV/EBITDA | 477.46 |
| Dividend yield | — |
| Beta | — |
| Earnings per share | −0.4 TL |
| Book value per share | 5.8 TL |
| EBITDA | 2.5M TL |
| Net profit | −800.1M TL |
| Operating profit | −25.6M TL |
| Operating profit before finance costs | −878.1M TL |
| Net working capital | 235M TL |
| Gross margin | 25.26% |
| Operating margin | −9.55% |
| Net margin | −298.85% |
| Return on assets | −5.88% |
| Return on equity | −6.74% |
| Current ratio | 4.23 |
| Quick ratio | 3.57 |
| Cash ratio | — |
| Leverage ratio | 11.41 |
| Debt to equity | 0.13 |
| Debt to assets | 0.11 |
| Fixed assets to equity | 1.02 |
| Short-term debt share | 0.00 |
| Interest coverage | — |
| Receivables turnover | 0.49 |
| Days sales outstanding | 745 |
| Inventory turnover | 4.19 |
| Days inventory outstanding | 87 |
| Payables turnover | 4.20 |
| Days payables outstanding | 87 |
| Working capital turnover | 1.14 |
| Equity turnover | 0.09 |
| Asset turnover | 0.08 |
Frequently Asked Questions
What is the P/E ratio of RTALB?
RTALB has a P/B ratio of 0.35 and an EV/EBITDA of 477.46.
When are the ratios updated?
Price-based ratios (P/E, P/B, EV/EBITDA, dividend yield) refresh daily; balance-sheet ratios refresh after the company publishes its KAP financial report.